{"id":3970,"date":"2023-01-18T11:37:58","date_gmt":"2023-01-18T10:37:58","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/"},"modified":"2023-01-18T11:37:58","modified_gmt":"2023-01-18T10:37:58","slug":"actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021"},"content":{"rendered":"\r\n<p><strong>Degeneraci\u00f3n macular asociada a la edad: tratamiento y perspectivas<\/strong><\/p>\r\n\r\n\r\n\r\n<p><strong><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/04\/0v2_AFTV19N4-WEB.pdf\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021<\/a><\/strong><\/p>\r\n\r\n\r\n\r\n<p><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-3-Sumario.pdf\">\u00cdndice<\/a><\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\"><li><strong>Editorial del presidente<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-01-Edit-presidente.pdf\">La farmacolog\u00eda en tiempos de pandemia<\/a> <\/li><\/ul><\/li><li><strong>Editorial del director<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-02-Edit-director.pdf\">25 a\u00f1os de la Fundaci\u00f3n Te\u00f3filo Hernando<\/a> <\/li><\/ul><\/li><li><strong>Editorial invitado<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-03A-Editorial-invitado.pdf\">Uso de SYSADOA y riesgo de infarto agudo de miocardio<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-03B-Editorial-invitado.pdf\">Inhibidores de SGLT2: protegen al ri\u00f1\u00f3n y al coraz\u00f3n&#8230; Y tambi\u00e9n tratan la diabetes tipo 2<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-03C-Editorial-invitado.pdf\">Francisco Guerra. Farmac\u00f3logo, historiador y bibli\u00f3filo<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/04\/0_AFTV19N4-03D-Editorial-invitado.pdf\">Molnupiravir and paxlovid \u2013 how much is genomic and protein destabilization harmful to SARS-COV-2 survival and resistance?<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-03E-Editorial-invitado.pdf\">Medicamentos de terapia avanzada; \u00bfel futuro ya est\u00e1 aqu\u00ed?<\/a> <\/li><\/ul><\/li><li><strong>Art\u00edculo de opini\u00f3n<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-04-Art-opinion.pdf\">Informes de posicionamiento terap\u00e9utico: \u00bfayuda o restricci\u00f3n en el tratamiento?<\/a> <\/li><\/ul><\/li><li><strong>Investigaci\u00f3n traslacional<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-05A-Inv-traslacional.pdf\">Anticuerpos monoclonales<\/a> <\/li><\/ul><\/li><li><strong>Revisiones en farmacoterapia<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-06A-Revisiones-en-farmacoterapia.pdf\">Degeneraci\u00f3n macular asociada a la edad: tratamiento y perspectivas<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-06B-Revisiones-en-farmacoterapia-1.pdf\">La tuberculosis multirresistente: novedades en el tratamiento de una epidemia global que pone en riesgo la salud p\u00fablica<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-06C-Revisiones-en-farmacoterapia-1.pdf\">Farmacoterapia de la obesidad: definiendo una nueva enfermedad<\/a> <\/li><\/ul><\/li><li><strong>Cultura y f\u00e1rmacos<\/strong> <ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-10-CYF-1.pdf\">\u2018Aceite de castor\u2019 (paremias-2)<\/a> <\/li><\/ul><\/li><\/ul>\r\n\r\n\r\n\r\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\"><\/figure>\r\n","protected":false},"featured_media":3037,"template":"","categoria_revista":[66],"class_list":["post-3970","revista","type-revista","status-publish","has-post-thumbnail","hentry","categoria_revista-2021-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Degeneraci\u00f3n macular asociada a la edad: tratamiento y perspectivas Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 \u00cdndice Editorial del presidente La farmacolog\u00eda en tiempos de pandemia Editorial del director 25 a\u00f1os de la Fundaci\u00f3n Te\u00f3filo Hernando Editorial invitado Uso de SYSADOA y riesgo de infarto agudo de miocardio Inhibidores de SGLT2: protegen ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/\",\"url\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-1-Portada.jpg\",\"datePublished\":\"2023-01-18T10:37:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#primaryimage\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-1-Portada.jpg\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-1-Portada.jpg\",\"width\":1522,\"height\":2152},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.socesfar.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\/\/www.socesfar.es\/en\/revistas\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.socesfar.es\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Socesfar\",\"https:\/\/www.linkedin.com\/company\/socesfar\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Degeneraci\u00f3n macular asociada a la edad: tratamiento y perspectivas Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 \u00cdndice Editorial del presidente La farmacolog\u00eda en tiempos de pandemia Editorial del director 25 a\u00f1os de la Fundaci\u00f3n Te\u00f3filo Hernando Editorial invitado Uso de SYSADOA y riesgo de infarto agudo de miocardio Inhibidores de SGLT2: protegen ... Read more","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-1-Portada.jpg","datePublished":"2023-01-18T10:37:58+00:00","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#primaryimage","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-1-Portada.jpg","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2022\/01\/AFTV19N4-0-1-Portada.jpg","width":1522,"height":2152},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-4-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 4, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/3970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":0,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/3970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media\/3037"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=3970"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=3970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}